RESUMEN
Combined internal medicine and dermatology (med-derm) training programs were created to advance complex medical dermatology and inpatient dermatology care. A prior study demonstrated that compared to categorical dermatology residents, med-derm residents had less program satisfaction, yet indicated a stronger desire to pursue careers in academia. No follow-up data on practice patterns after training has been reported. We aimed to characterize differences in residency program satisfaction and practice patterns between physicians trained in categorical dermatology compared to med-derm residency programs. We surveyed physicians who graduated from combined med-derm programs along with their counterparts, from six institutions, that either currently or historically had a combined med-derm training, from 2008-2017. Fifty-five percent of med-derm and forty-one percent of categorical-trained physicians responded. The practice patterns between the two groups were similar. A quarter of med-derm physicians continued to provide general internal medicine services. Categorical trained physicians were significantly more satisfied with their training (P=0.03) and performed more excisions on the head/neck (P=0.02). The combined graduates had significantly greater confidence in multidisciplinary care (P=0.003), prescribed more biologic (P<0.001) and non-biologic immunosuppressive agents (P=0.002), and volunteered more for the underserved patients in their communities (P=0.04). Although few differences in overall practice patterns between categorical and med-derm trained graduates were appreciated, med-derm graduates seem more comfortable with multidisciplinary care and may care for more medically complex patients requiring immunosuppression.
Asunto(s)
Dermatología , Internado y Residencia , Médicos , Humanos , Medicina Interna , CabezaRESUMEN
Alopecia areata/AA is an autoimmune cause of nonscarring hair loss. The pathogenesis of AA involves many immune axes, including Th1/Th2 pathways. Delgocitinib is a pan-Janus kinase/JAK inhibitor that broadly blocks pro-inflammatory cytokines and has been effective in other inflammatory skin conditions. Recent human studies/reports have shown that use of some systemic JAK inhibitors led to hair regrowth, suggesting this medication class as a potential therapy for AA. However, topical treatment is desirable due to potential systemic side effects. To assess the efficacy and safety of topical delgocitinib in AA, we conducted a double-blind, randomized, vehicle-controlled clinical trial in 31 moderate-to-severe AA patients that were randomized 2:1 to receive delgocitinib ointment 30 mg/g (n = 20) or ointment vehicle (n = 11) for 12 weeks. The primary endpoint was change in severity of Alopecia Tool/SALT score from baseline to week 12. The secondary endpoint included safety profile by reported adverse events. Twenty-three subjects completed the trial, with eight discontinuing mostly due to voluntary withdrawal. Ten patients receiving delgocitinib ointment and three patients receiving vehicle showed SALT score improvements after 12 weeks, but the mean percent SALT improvement at week 12 compared to baseline between the two arms was not significant (p = 0.92). Our study suggests that delgocitinib ointment is not effective in moderate-to-severe AA, likely due to its inability to penetrate sufficiently deeply into the dermis of the scalp, but larger studies are necessary to assess whether a different formulation of topical JAK inhibitors may be suitable to treat mild or more localized forms of AA.
Asunto(s)
Alopecia Areata , Inhibidores de las Cinasas Janus , Humanos , Alopecia Areata/tratamiento farmacológico , Inhibidores de las Cinasas Janus/efectos adversos , Pomadas/uso terapéutico , Resultado del TratamientoRESUMEN
BACKGROUND: Janus kinase (JAK) activation is suggested to have a pathological role in alopecia areata (AA). CTP-543, a deuterated compound that selectively inhibits JAK1 and JAK2, is being developed as an oral treatment for AA. OBJECTIVE: To assess the safety and efficacy of a 24-week regimen of CTP-543 in patients with chronic, moderate-to-severe AA. METHODS: In this phase 2, randomized, double-blind, placebo-controlled, sequential-design trial, patients were randomized to receive CTP-543 (4 mg, 8 mg, or 12 mg) or placebo every 12 hours for 24 weeks. RESULTS: A dose-related increase was observed in the percentage of patients with ≥50% relative reduction in Severity of Alopecia Tool scores from baseline at week 24 (9% placebo, 21% 4 mg twice daily, 47% 8 mg twice daily, and 58% 12 mg twice daily), with statistical significance versus placebo (P < .001) observed for the 8-mg twice daily and 12-mg twice daily groups, with differences from placebo noted as early as 12 weeks after the initiation of treatment. Safety results were consistent with the known safety profiles of JAK inhibitors. LIMITATIONS: These initial findings are from a relatively small controlled trial, and additional studies are needed to fully characterize the safety and efficacy of CTP-543 in adult patients with AA. CONCLUSIONS: Patients treated with CTP-543 (8 or 12 mg, twice daily) had a significant reduction in the severity of AA.
Asunto(s)
Alopecia Areata , Inhibidores de las Cinasas Janus , Adulto , Alopecia Areata/inducido químicamente , Alopecia Areata/tratamiento farmacológico , Citidina Trifosfato/uso terapéutico , Humanos , Inhibidores de las Cinasas Janus/efectos adversos , Pirimidinas/efectos adversos , Resultado del TratamientoRESUMEN
Dermatological diagnosis remains challenging for nonspecialists because the morphologies of primary skin lesions widely vary from patient to patient. Although previous studies have used artificial intelligence (AI) to classify lesions as benign or malignant, there have not been extensive studies examining the use of AI on identifying and categorizing a primary skin lesion's morphology. In this study, we evaluate the performance of a standalone AI tool to correctly categorize a skin lesion's morphology from a test bank of images. To provide a marker of performance, we evaluate the accuracy of primary care physicians to categorize skin lesion morphology in the same test bank of images without any aids and then with the aid of a simple visual guide. The AI system achieved an accuracy of 68% in determining the single most likely morphology from the test image bank. When the AI's top prediction was broadened to its top three most likely predictions, accuracy improved to 80%. In comparison, the diagnostic accuracy of primary care physicians was 36% without any aids and 68% with the visual guide (P < 0.001). The AI was subsequently tested on an additional set of 222 heterogeneous images of varying Fitzpatrick skin types and achieved an overall accuracy of 70% in the Fitzpatrick I-III skin type group and 68% in the Fitzpatrick IV-VI skin type group (P = 0.79). An AI is a powerful tool to assist physicians in the diagnosis of skin lesions while still requiring the user to critically consider other possible diagnoses.
Asunto(s)
Inteligencia Artificial , Sistemas de Atención de Punto , Enfermedades de la Piel/diagnóstico , HumanosAsunto(s)
Educación de Pregrado en Medicina/métodos , Melanoma/diagnóstico , Reconocimiento Visual de Modelos , Neoplasias Cutáneas/diagnóstico , Diagnóstico Diferencial , Humanos , Queratosis Seborreica/diagnóstico , Queratosis Seborreica/patología , Lentigo/diagnóstico , Lentigo/patología , Melanoma/patología , Nevo/diagnóstico , Nevo/patología , Nevo Azul/diagnóstico , Nevo Azul/patología , Estudios Prospectivos , Neoplasias Cutáneas/patología , Estudiantes de Medicina , Percepción VisualRESUMEN
Factitious disorder imposed on self is characterized by self-induction. Dermatitis artefacta, the cutaneous subtype of factitious disorder imposed on self, can have a variety of atypical presentations. A 36-year-old woman with an extensive past medical history presented with painful nodules on her abdomen, thighs, and arms. Histologic evaluation identified panniculitis with foreign body material seen under polarization. Chart review from previous hospital visits established a history of factitious disorder imposed on self and upon subsequent search of the hospital room, syringes with an unknown substance were found. Factitial panniculitis should be considered in cases with atypical lesions or locations that do not conform to the presentation of organic causes of panniculitis. Management should include a multidisciplinary approach that prioritizes patient safety and establishes a therapeutic patient-provider relationship.
Asunto(s)
Trastornos Fingidos/diagnóstico , Cuerpos Extraños/patología , Paniculitis/patología , Piel/patología , Adulto , Femenino , Humanos , Paniculitis/diagnósticoRESUMEN
Topical minoxidil is a well-known and often-utilized drug in dermatological practice for the treatment of alopecia. It was approved by the United States Food and Drug Administration for the treatment of androgenetic alopecia in 1988. Since its approval, minoxidil has been used off-label for the treatment of many other types of alopecia, with minimal formal evidence of efficacy. Conditions for which the use of topical minoxidil has been reported include telogen effluvium, alopecia areata (AA), scarring alopecia, eyebrow hypotrichosis, monilethrix, and chemotherapy-induced alopecia (CIA). The evidence for the use of minoxidil in each condition is derived from a variety of studies, including clinical trials, case series, and case reports. A comprehensive review of the literature indicates that while minoxidil is routinely used in the management of many alopecic conditions, there is mixed evidence for its efficacy. For certain conditions, including AA and most scarring alopecias, the evidence seems to be inconclusive. For others, such as eyebrow hypotrichosis, monilethrix, early traction alopecia, and CIA, there is more support for the efficacy of minoxidil. Although the favorable safety profile of minoxidil is established in adults, its use in the treatment of pediatric alopecia may require heightened monitoring and patient education.
Asunto(s)
Alopecia/tratamiento farmacológico , Minoxidil/administración & dosificación , Uso Fuera de lo Indicado , Administración Tópica , Adulto , Alopecia/patología , Animales , Humanos , Minoxidil/efectos adversos , Resultado del Tratamiento , Vasodilatadores/administración & dosificación , Vasodilatadores/efectos adversosRESUMEN
IMPORTANCE: Residency applicants often use social media to discuss the positive and negative features of prospective training programs. An examination of the content discussed by applicants could provide guidance for how a medical education faculty can better engage with prospective trainees and adapt to meet the educational expectations of a new generation of digital-native physicians. OBJECTIVE: The objective was to identify unstructured social media data submitted by residency applicants and categorize positive and negative statements to determine key themes. DESIGN: The study design was qualitative analysis of a retrospective cohort. SETTING: Publicly available datasets were used. PARTICIPANTS: The participants were anonymized medical trainees applying to residency training positions in 9 specialties-dermatology, general surgery, internal medicine, obstetrics/gynecology, plastic surgery, otolaryngology, physical medicine and rehabilitation, pediatrics, and radiology-from 2007 to 2017. MAIN OUTCOMES AND MEASURES: After we developed a standardized coding scheme that broke comments down into major features, themes, and subthemes, all unstructured comments were coded by two independent researchers. Positive and negative comments were coded separately. Frequency counts and percentages were recorded for each identified feature, theme, and subtheme. The percent positive and negative comments by specialty were also calculated. RESULTS: Of the 6314 comments identified, 4541 were positive and 1773 were negative. Institution was the most commonly cited major feature in both the positive (nâ¯=â¯767 [17%]) and negative (nâ¯=â¯827 [47%]) comments. Geography was the most cited theme, and City, Cost of Living, and Commute were commonly cited subthemes. Training was the next most cited major feature in both positive (nâ¯=â¯1005 [22%]) and negative (nâ¯=â¯291 [16%]) comments, with Clinical Training being more commonly cited compared to Research Opportunities. Overall, 72% of comments from all were positive; however, the percent of comments that were positive comments varied significantly across the 9 specialties. Pediatrics (65%), dermatology (66%), and internal medicine (68%) applicants were more likely to express negative comments compared with the global average, but physical medicine and rehabilitation (85%), radiology (82%), otolaryngology (81%), and plastic surgery (80%) applicants were more likely to express positive comments. CONCLUSIONS AND RELEVANCE: This qualitative analysis of positive and negative themes as posted by applicants in recent matching years is the first and provides new detailed insights into the motivations and desires of trainees.
Asunto(s)
Actitud del Personal de Salud , Internado y Residencia , Medios de Comunicación Sociales , Selección de Profesión , Estudios de Cohortes , Estudios Transversales , Educación de Postgrado en Medicina , Humanos , Estudios RetrospectivosRESUMEN
A 33-year-old female with a 7-year history of CD8-positive hypopigmented mycosis fungoides (MF) involving the trunk and extremities presented with a large well-defined alopecic patch on her frontal scalp. Clinically, this area resembled alopecia areata (AA) and was without hypopigmentation or erythema. A scalp biopsy revealed a non-scarring inflammatory alopecia and a superficial band-like atypical lymphoid infiltrate with prominent epidermotropism. Atypical, predominately CD8-positive lymphocytes were seen surrounding and infiltrating the bulb portion of several hair follicles. Treatments for her MF lesions have included topical bexarotene, topical corticosteroids and phototherapy. Her alopecia has been treated with high potency topical corticosteroids and multiple intralesional triamcinolone injections with very minimal hair regrowth to date. Alopecia due to cutaneous lymphoma is an uncommon phenomenon but can occur in erythrodermic MF or Sezary syndrome. AA-like changes have most often been reported in conventional patch/plaque stage MF and folliculotropic MF. In these cases, the atypical lymphoid infiltrate is comprised predominately of CD4-positive lymphocytes. This is a rare report of a CD8-positive MF causing AA-like changes. This case highlights the importance of a scalp biopsy in patients with a history of cutaneous lymphoma presenting with alopecia in order to evaluate the nature of their hair loss.
Asunto(s)
Alopecia Areata/etiología , Linfocitos T CD8-positivos/patología , Micosis Fungoide/complicaciones , Neoplasias Cutáneas/complicaciones , Adulto , Femenino , Humanos , Micosis Fungoide/patología , Recurrencia Local de Neoplasia/complicaciones , Recurrencia Local de Neoplasia/patología , Neoplasias Cutáneas/patologíaRESUMEN
Clinical practice gaps exist in the care of hair patients. Attitude gaps include a relative lack of dermatologists interested in caring for patients with hair complaints, a potential underestimation of the effect of hair disorders on the quality of patients' lives, and potential failure to recognize the presentation of body dysmorphic disorder among patients with hair complaints. Knowledge gaps regarding the prevalence and presentation of hair loss disorders may lead to a delay in diagnosis and treatment of hair patients. Skill gaps in physical examination, particularly with dermoscopy of the scalp and hair, may affect the care of hair patients.
Asunto(s)
Actitud del Personal de Salud , Competencia Clínica , Dermatología/educación , Enfermedades del Cabello/diagnóstico , Dermatología/normas , Dermoscopía , Enfermedades del Cabello/terapia , Humanos , Internado y Residencia , Calidad de VidaRESUMEN
BACKGROUND: Hair loss may significantly impact an individual's self-image, and studies indicate that patients with both clinically apparent and clinically imperceptible hair loss may have significantly decreased quality of life (QoL). Moreover, clinical severity of hair loss does not necessarily predict impact on QoL. OBJECTIVE: The aim of this study was to assess QoL in patients (n = 104) with alopecia areata, telogen effluvium, and androgenic alopecia, and to compare QoL with hair loss severity (HLS) as independently rated by both patient and dermatologist. METHODS: Questionnaires and clinical assessment tools were used to assess HLS, and QoL was measured by completion of Skindex-16. RESULTS: Overall, patients rated their hair loss as more severe than the dermatologist, and the patient's HLS rating more strongly correlated with QoL than the dermatologist's rating. Clinical assessment of HLS did not reliably predict the patient's QoL, nor did it predict the patient's perception of HLS. LIMITATIONS: A convenience sample was recruited from a referral clinic and Skindex-16 has not been validated for use in women's alopecia disorders. CONCLUSION: These findings indicate dermatologists should address these psychosocial and QoL issues when treating patients with alopecia.